Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Cancer ; 9: 267, 2009 Aug 03.
Article in English | MEDLINE | ID: mdl-19650921

ABSTRACT

BACKGROUND: Our objective was to assess the histological changes in mammary glands of the female Wistar-Furth rat as a result of low dose exposure to N-nitrosomethylurea (NMU). METHODS: Groups of 30-40 virgin female rats of between 49-58 days old received a single injection of 10, 20, 30 or 50 mg NMU/kg body weight (BW). A group of 10 control rats received 0.9% NaCl solution only. The formation of palpable mammary gland tumors was assessed weekly and, upon sacrifice at 12, 22 and 25-30 weeks after treatment, we performed a comprehensive histological analysis of all mammary gland lesions and tumors. RESULTS: Alongside the predicted increase in tumor number and decrease in tumor latency with increasing NMU dose, we observed a number of microscopic lesions and other epithelial abnormalities in the mammary glands for all NMU doses. Two types of non-neoplastic histological changes were observed in rats exposed to 10 or 20 mg NMU/kg BW: namely, (i) an increase in the number of acinar structures often accompanied by secretion into the lumen which is normally associated with pregnancy and lactation, and (ii) an increase in the number of epithelial cells sloughed into the lumen of the epithelial ducts. CONCLUSION: This study establishes a baseline for low-dose exposure and defines the histological features in the mammary gland resulting from NMU exposure. Furthermore, this system provides an ideal platform for evaluating the relative susceptibility of animals protected from, or predisposed to, developing cancer through environmental influences.


Subject(s)
Mammary Glands, Animal/drug effects , Mammary Neoplasms, Animal/chemically induced , Methylnitrosourea/pharmacology , Animals , Body Weight , Disease Models, Animal , Female , Mammary Neoplasms, Experimental/pathology , Rats , Rats, Wistar , Species Specificity , Time Factors
2.
Reprod Toxicol ; 26(3-4): 210-9, 2008.
Article in English | MEDLINE | ID: mdl-18938238

ABSTRACT

Humans are routinely exposed to bisphenol-A (BPA), an estrogenic compound that leaches from consumer products. Given the sensitivity of the developing organism to hormones, exposure of fetuses and infants is a concern. Here, CD-1 mice were exposed to environmentally relevant doses of BPA during gestation and the lactational period (gestational day 8 through postnatal day 16). At 3, 9 and 12-15 months of age, mammary glands from exposed offspring were examined for structural changes. BPA-exposed females demonstrated altered mammary phenotypes including the appearance of alveolar buds. Additionally, intraductal hyperplasias were observed exclusively in BPA-exposed females. These lesions had the appearance of "beaded" ducts, with epithelial cells present inside the ductal lumen and increased proliferation indexes compared to normal ducts. Similar structures have also been observed following exposure to other estrogens. These results are further evidence that perinatal BPA exposure can alter the morphology of the rodent mammary gland in adulthood.


Subject(s)
Mammary Glands, Animal/drug effects , Phenols/toxicity , Animals , Animals, Newborn , Benzhydryl Compounds , Cell Proliferation/drug effects , Female , Hyperplasia , Mammary Glands, Animal/pathology , Mice , Receptors, Progesterone/analysis
3.
Reprod Toxicol ; 23(3): 383-90, 2007.
Article in English | MEDLINE | ID: mdl-17123778

ABSTRACT

Exposure of the fetus to excess estrogen is believed to increase the risk of developing breast cancer during adult life. Fetal exposure to low doses of the xenoestrogen bisphenol A resulted in long-lasting effects in the mouse mammary gland that were manifested during adult life. It enhanced sensitivity to estradiol, decreased apoptosis, increased the number of progesterone receptor-positive epithelial cells at puberty and increased lateral branching at 4 months of age. We now report that fetal exposure to 2.5, 25, 250 and 1000 microg bisphenol A/kg body weight/day induces the development of ductal hyperplasias and carcinoma in situ at postnatal day 50 and 95 in rats. These highly proliferative lesions have an increased number of estrogen receptor-alpha positive cells. Thus, fetal bisphenol A exposure is sufficient to induce the development of preneoplastic and neoplastic lesions in the mammary gland in the absence of any additional treatment aimed at increasing tumor development.


Subject(s)
Carcinoma in Situ/chemically induced , Mammary Glands, Animal/drug effects , Mammary Neoplasms, Animal/chemically induced , Phenols/toxicity , Animals , Animals, Newborn , Benzhydryl Compounds , Carcinoma in Situ/metabolism , Carcinoma in Situ/pathology , Dose-Response Relationship, Drug , Estrogen Receptor alpha/metabolism , Estrogens, Non-Steroidal/administration & dosage , Estrogens, Non-Steroidal/toxicity , Female , Fetal Development/drug effects , Hyperplasia , Immunochemistry , Male , Mammary Glands, Animal/chemistry , Mammary Glands, Animal/pathology , Mammary Neoplasms, Animal/metabolism , Mammary Neoplasms, Animal/pathology , Phenols/administration & dosage , Precancerous Conditions/chemically induced , Precancerous Conditions/pathology , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Wistar , Time Factors
4.
Ultrastruct Pathol ; 30(6): 489-503, 2006.
Article in English | MEDLINE | ID: mdl-17182441

ABSTRACT

In this report, the authors summarize their 19-year experience with over 200 biochemically proven cases of lysosomal storage diseases using electron microscopic screening of more than 950 skin biopsies. They found that electron microscopy (EM) is a highly sensitive, efficient, cost-effective, and rapid diagnostic screening tool for evaluation of lysosomal storage diseases in skin biopsies. Although EM is more expensive than a single enzyme assay, it can exclude more than 90% of cases in which lysosomal storage disease is being considered. EM is critical for diagnosis of neuronal ceroid lipofuscinosis and mucolipidosis IV and is the most cost-effective screening tool in patients with previously unrecognized storage diseases.


Subject(s)
Lysosomal Storage Diseases/diagnosis , Skin/ultrastructure , Biopsy/economics , Child , Cost-Benefit Analysis , Female , Humans , Male , Microscopy, Electron, Transmission , Middle Aged
5.
Immunity ; 25(3): 429-40, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16973388

ABSTRACT

Systemic lupus erythematosus (SLE) is characterized by the production of autoantibodies that are frequently directed against nucleic acid-associated antigens. To better understand how B cells reactive with such antigens are regulated, we generated a model system in which heavy and light chain genes encoding 564 immunoglobulin have been targeted to the heavy and light chain loci of the nonautoimmune C57BL/6 mouse strain. This antibody recognizes RNA, single-stranded DNA, and nucleosomes. We show that B cells expressing this immunoglobulin were activated, producing class-switched autoantibody in vivo despite the apparently normal induction of anergy. This autoantibody production was largely dependent on Toll-like receptor 7 (TLR7). We further show that production of these autoantibodies was sufficient to cause kidney pathology in these mice. These results demonstrate that the particular threat of nucleic acid-containing autoantigens lies in their ability to bind both antigen receptor and TLR7.


Subject(s)
Autoantibodies/biosynthesis , B-Lymphocytes/immunology , Immune Tolerance , Lupus Erythematosus, Systemic/genetics , Lupus Erythematosus, Systemic/immunology , Membrane Glycoproteins/physiology , Toll-Like Receptor 7/physiology , Animals , Autoantibodies/physiology , B-Lymphocytes/metabolism , Cell Line, Tumor , Female , Humans , Immune Tolerance/genetics , Lupus Erythematosus, Systemic/pathology , Membrane Glycoproteins/deficiency , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Toll-Like Receptor 7/deficiency , Toll-Like Receptor 7/genetics
6.
Pathol Res Pract ; 201(12): 803-8, 2005.
Article in English | MEDLINE | ID: mdl-16308105

ABSTRACT

CD3 antigen, formerly thought to be specific for T lymphocytes, has been identified in Purkinje cells of the cerebellum and gastric parietal cells in several species, including humans. The antibodies commonly used to recognize CD3 are directed against the epsilon-subunit of the T cell receptor. This subunit has a role in signal transduction in T lymphocytes and possibly other types of cells. We immunostained sections for CD3 from normal kidneys of several species, including humans, and from different primary human renal cortical neoplasms to determine if CD3 antigen is expressed in normal and in neoplastic tubular epithelium. CD3 expression was strong in normal proximal and distal tubular epithelium in most species and in renal oncocytomas, weak in chromophobe carcinoma, and negative in clear cell carcinomas, in papillary renal cell carcinoma, and in a transitional cell carcinoma. These findings suggest that this marker may be useful in the diagnostic workup and classification of renal cortical neoplasms.


Subject(s)
Adenoma, Oxyphilic/metabolism , CD3 Complex/metabolism , Kidney Neoplasms/metabolism , Kidney Tubules/metabolism , Animals , Epithelium/metabolism , Humans
7.
Mol Genet Metab ; 82(2): 137-43, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15172001

ABSTRACT

The allelic autosomal recessive lysosomal storage disorders Salla disease and infantile free sialic acid storage disease (ISSD) result from mutations in SLC17A5. This gene codes for sialin, a lysosomal membrane protein that transports the charged sugar, N-acetylneuraminic acid (sialic acid), out of lysosomes. ISSD has a severe phenotype with infantile onset, while the Finnish variant, Salla disease, has a milder phenotype with later onset. Both disorders cause developmental delay, and ISSD is generally fatal in early childhood. We describe a 30-month old non-Finnish, Caucasian child with global developmental delay of postnatal onset, language, and motor skills stagnant at a 3-4 month level, hypotonia, and mild but progressive coarsening of facial features. Urinary excretion of free sialic acid was elevated 4.5 times above control. EM of a skin biopsy revealed enlarged secondary lysosomes consistent with oligosaccharide storage. Free sialic acid in fibroblasts was 3.8+/-0.9 nmol/mg protein (concurrent normal controls, 0.5+/-0.1); differential centrifugation indicated a lysosomal location. Genomic analysis revealed compound heterozygosity for two new SLC17A5 mutations. This child's clinical manifestations of a lysosomal free sialic acid storage disease are consistent with her sialin mutations and biochemical findings. The differential diagnosis of postnatal developmental delay should include free sialic acid storage disorders such as ISSD and Salla disease.


Subject(s)
Sialic Acid Storage Disease/diagnosis , Sialic Acid Storage Disease/physiopathology , Base Sequence , Brain/diagnostic imaging , Child, Preschool , DNA Mutational Analysis , Exons/genetics , Female , Fibroblasts , Humans , Infant , Lysosomes/ultrastructure , Male , N-Acetylneuraminic Acid/analysis , N-Acetylneuraminic Acid/urine , Organic Anion Transporters/genetics , Radionuclide Imaging , Sialic Acid Storage Disease/genetics , Sialic Acid Storage Disease/metabolism , Skin/ultrastructure , Symporters/genetics
8.
J Cell Sci ; 117(Pt 8): 1495-502, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-14996910

ABSTRACT

A complex network of interactions between the stroma, the extracellular matrix and the epithelium drives mammary gland development and function. Two main assumptions in chemical carcinogenesis of the mammary gland have been that carcinogens induce neoplasia by causing mutations in the DNA of the epithelial cells and that the alterations of tissue architecture observed in neoplasms are a consequence of this primary mutational event. Here, we use a rat mammary tissue recombination model and the chemical carcinogen N-nitrosomethylurea (NMU) to determine whether the primary target of the carcinogen is the epithelium, the stroma or both tissue compartments. Mammary epithelial cells were exposed in vitro either to the carcinogen or vehicle before being transplanted into the cleared fat pads of rats exposed to carcinogen or vehicle. We observed that neoplastic transformation of these mammary epithelial cells occurred only when the stroma was exposed in vivo to NMU, regardless of whether or not the epithelial cells were exposed to the carcinogen. Mammary epithelial cells exposed in vitro to the carcinogen formed phenotypically normal ducts when injected into a non-treated stroma. Mutation in the Ha-ras-1 gene did not correlate with initiation of neoplasia. Not only was it often found in both cleared mammary fat pads of vehicle-treated animals and intact mammary glands of untreated animals, but it was also absent in some tumors. Our results suggest that the stroma is a crucial target of the carcinogen and that mutation in the Ha-ras-1 gene is neither necessary nor sufficient for tumor initiation.


Subject(s)
Epithelial Cells/metabolism , Epithelial Cells/transplantation , Mammary Glands, Animal/cytology , Mammary Glands, Animal/metabolism , Mammary Neoplasms, Experimental/etiology , Stromal Cells/drug effects , Alkylating Agents/pharmacology , Animals , Carcinogens/pharmacology , Cell Transformation, Neoplastic/drug effects , Cells, Cultured , Epithelial Cells/cytology , Epithelial Cells/drug effects , Extracellular Matrix/metabolism , Female , Genes, ras , Mammary Glands, Animal/growth & development , Methylnitrosourea/pharmacology , Mutation/drug effects , Neoplasm Transplantation , Rats , Rats, Inbred WF , Stromal Cells/cytology , Stromal Cells/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...